Ascentage Pharma Group International (AAPG) Enterprise Value (2022 - 2024)
Historic Enterprise Value for Ascentage Pharma Group International (AAPG) over the last 3 years, with Q4 2024 value amounting to -$124.3 million.
- Ascentage Pharma Group International's Enterprise Value rose 1376.01% to -$124.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$124.3 million, marking a year-over-year increase of 1376.01%. This contributed to the annual value of -$124.3 million for FY2024, which is 1257.17% up from last year.
- Per Ascentage Pharma Group International's latest filing, its Enterprise Value stood at -$124.3 million for Q4 2024, which was up 1376.01% from -$144.2 million recorded in Q4 2023.
- In the past 5 years, Ascentage Pharma Group International's Enterprise Value ranged from a high of -$124.3 million in Q4 2024 and a low of -$189.2 million during Q4 2022
- For the 3-year period, Ascentage Pharma Group International's Enterprise Value averaged around -$152.6 million, with its median value being -$144.2 million (2023).
- In the last 5 years, Ascentage Pharma Group International's Enterprise Value soared by 2380.02% in 2023 and then skyrocketed by 1376.01% in 2024.
- Quarter analysis of 3 years shows Ascentage Pharma Group International's Enterprise Value stood at -$189.2 million in 2022, then increased by 23.8% to -$144.2 million in 2023, then grew by 13.76% to -$124.3 million in 2024.
- Its Enterprise Value was -$124.3 million in Q4 2024, compared to -$144.2 million in Q4 2023 and -$189.2 million in Q4 2022.